-
2x Big Product launched in 1Q11 (Mcap 5 M) 300-500% Potential
Here is the next Winner which is wayyyy undervalued . 2 Great Products launched in 1Q 2011 means the Company now starts making money .
Market cap of less that 5 Million is really a Big Joke . Duromist is the GAME CHANGER for Novadel NDA filing is planned for 4Q 2011.They have enough cash for 1 year excluding Upfront Payments from upcoming Partnership .
Do your due Diligence and then load up the Truck .GL
Novadel (NVDL.OB)
Market Cap : 4.6 M
Cash : 1.6 M
Price: 0.04 $
Partnership for Duromist in 1H 2011
NDA filing for Duromist for the treatment of erectile dysfunction in 4Q 2011
In January 2011, NitroMist for the treatment of angina was launched in the U.S. by our marketing partner Akrimax Pharmaceuticals.
In February 2011, Zolpimist for the treatment of insomnia was launched in the U.S. by our marketing partner ECR Pharmaceuticals, a subsidiary of Hi-Tech Pharmacal.
We successfully completed our pilot PK study for Duromist™, our sildenefil oral spray product, and are moving forward with a clinical program with an anticipated filing of an NDA by the end of 2011.
“Our 2010 results represent an improvement over the prior year results. We ended 2010 with a modest amount of cash, however this amount was buttressed in the first quarter of 2011 by a milestone payment from a licensee, a grant from the U.S. government, and a capital raise. In addition, our licensees launched our NitroMist® and Zolpimist™ products in early 2011. We believe NitroMist and Zolpimist will be well accepted in the marketplace, and we anticipate the initiation of royalty revenue in 2011,” remarked Steven B. Ratoff, our Chairman and CEO. “We believe our efforts provide a foundation for the further development of our product pipeline and we will continue to progress the development of Duromist as well as control our costs during 2011.”
Recent Accomplishments
In January 2011, we received a $500,000 milestone payment from Akrimax Pharmaceuticals.
In January 2011, NitroMist was launched in the U.S. by our marketing partner Akrimax Pharmaceuticals.
In February 2011, Zolpimist was launched in the U.S. by our marketing partner ECR Pharmaceuticals, a subsidiary of Hi-Tech Pharmacal.
In February 2011, we received $244,479 for the grant awarded in 2010 under the IRS’ Qualifying Therapeutic Discovery Project program.
In February 2011, we received gross proceeds of $1.6 million from the sale of 1,667 shares of our preferred stock.
-
This is the perfect time to buy or add more shares of this undiscovered Stock .Im sure that Shareholders will be very very happy in the near future .Looking to add another 250k-500k shares next Week .
Good Potential here to see 3-5$ with FDA approval for Viagra Spray which will be the only on the Multi-Billion Dollar Market .GLTA
Market Cap 5.64 M
Price: 0.049 $
Pipeline
NovaDel » NVD-401
Presentation
http://www.novadel.com/pdf/CorporatePresentation.pdf
Zolpimist (Insomnia) launched in Feb 2011 = 1.5 Billion Dollar Market Size
http://www.wsw.com/webcast/roth24/nvd/2__Slide7.JPG
Nitromist (Angina) launched in Jan 2011 = 200 Million Dollar Market Size
http://www.wsw.com/webcast/roth24/nvd/2__Slide10.JPG
Duromist (Erectile Dysfunction) NDA Approval in 2012 = Multi-Billion Dollar Market
http://www.wsw.com/webcast/roth24/nvd/2__Slide14.JPG
http://www.wsw.com/webcast/roth24/nvd/2__Slide13.JPG
http://www.wsw.com/webcast/roth24/nvd/2__Slide21.JPG
Duromist™ (Viagra Spray) Development Plan
•2011 - Marketing agreement for Duromist
•2011 – Complete PK based clinical trials and file NDA
•2012 – NDA approval
-
Load up while its still very very very cheap . NVDl will move higher today
-
Here is older article about Pfizer and Novadel regarding Viagra spray .A buyout or Partnership is still possible by Pfizer . Viagra goes off patent in 1Q 2012 .
Pfizer says considering OTC form of Viagra | Reuters
-
Good news like Parter deal and IND filing is imminent . Market cap of 10 million is a joke .
Time load up at current bargain level .glta
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules